NYSE:KH - China Kanghui Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China Kanghui Holdings is a holding company and conducts all of its business through its two wholly owned subsidiaries in China, Changzhou Kanghui Medical Innovation Co., Ltd. (Changzhou Kanghui) and Beijing Libeier. The Company is a domestic developer, manufacturer and marketer of orthopedic implants in People's Republic of China. The Company's orthopedic implant brands are Kanghui and Libeier. It sells two lines of orthopedic implant products, trauma and spine. Its major trauma products, used in the surgical treatment of bone fractures, include a range of nails, plates and screws. Its major spine products, used in the surgical treatment of spine disorders, include screws, meshes, interbody cages and fixation systems. On July 31, 2008, we acquired 100% of the equity interests of Beijing Libeier. On July 31, 2009, the Company established Shanghai Zhikang Medical Devices Co., Ltd. (Shanghai Zhikang), which is wholly owned by Changzhou Kanghui.

Receive KH News and Ratings via Email

Sign-up to receive the latest news and ratings for KH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNYSE:KH
Previous Symbol
CUSIPN/A
Phone+86-519-85195556

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

China Kanghui (NYSE:KH) Frequently Asked Questions

What is China Kanghui's stock symbol?

China Kanghui trades on the New York Stock Exchange (NYSE) under the ticker symbol "KH."

Has China Kanghui been receiving favorable news coverage?

Media coverage about KH stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. China Kanghui earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future.

How do I buy shares of China Kanghui?

Shares of KH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Kanghui's official website?

The official website for China Kanghui is http://www.kanghui.com/.

How can I contact China Kanghui?

China Kanghui's mailing address is No. 11 Changjiang North Road, Xinbei District, CHANGZHOU, JNG 213022, China. The company can be reached via phone at +86-519-85195556.


MarketBeat Community Rating for China Kanghui (NYSE KH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about China Kanghui and other stocks. Vote "Outperform" if you believe KH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel